Simvastatins – Zocor, Vytorin, and Simcor

Drug Safety Alert – March 2010

High doses of simvastatin, a cholesterol drug sold as Zocor, Vytorin, and Simcor, have been linked to a muscle condition known as rhabdomyolysis.

A warning from the Food and Drug Administration (FDA) cites research that found patients taking 80 mg of simvastatin were more prone to muscle injury than those on lower doses. According to FDA regulations, 80 mg is the highest approved dosage of Zocor.

While muscle injury, known as myopathy, is a risk connected to all statin medications, the link between rhabdomyolysis and high doses of simvastatin is especially strong. Due to this link, the FDA has revised the simvastatin warning label.

What is Zocor?

Zocor, sold generically as simvastatin, is a dangerous prescription medication used to lower cholesterol levels in the body. It is a member of the statin drug class.

Simvastatin was approved by the FDA in 1991. It is also sold in the United States as part of two combination medications:

• Vytorin (ezetimibe/simvastatin)
• Simcor (niacin/simvastatin)

Side Effects of Zocor and Simvastatin

Zocor has been linked to rhabdomyolysis, a form of myopathy responsible for the rapid buildup and breakdown of skeletal muscle.

Signs of Rhabdomyolysis

Have You Been Injured by Zocor or Simvastatin?

If you’ve experienced any of the above symptoms after taking simvastatin, Zocor, Vytorin, or Simcor, contact our law firm right away. Our drug injury attorneys aren’t afraid to stand up to the big pharmaceutical companies that produce unsafe medications and hold them accountable.

Don’t delay. If you’re experiencing rhabdomyolysis caused by Zocor, you may have a case. Find out today by taking advantage of our free online legal evaluation or by calling 1-866-9-4EDGAR.